Clinical Trials on Advanced Angiosarcoma

Total 7461 results

M.D. Anderson Cancer Center

Terminated

Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study

Locally Advanced Angiosarcoma | Metastatic Angiosarcoma | Recurrent Angiosarcoma

United States
Stanford University
Genentech, Inc.

Terminated

Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma

Soft Tissue Sarcoma | Angiosarcomas

United States
Tracon Pharmaceuticals Inc.

Completed

Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients With Advanced Angiosarcoma (TAPPAS)

Advanced Angiosarcoma

United States, France, Italy, Austria, Germany, Poland, Spain, United Kingdom
Radboud University Medical Center
Genzyme Europe B.V.

Completed

Cemiplimab for Secondary Angiosarcomas

Metastasis | Locally Advanced Sarcoma | Secondary Angiosarcoma

Netherlands
National Cancer Institute (NCI)

Active, not recruiting

Testing the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue Sarcoma

Skin Angiosarcoma | Skin Radiation-Related Angiosarcoma | Visceral Angiosarcoma

United States, Guam
National Cancer Center, Japan
Merck Sharp & Dohme LLC

Recruiting

Pembrolizumab Plus Lenvatinib in Unresectable Cutaneous Angiosarcoma Patients (PLAS)

Angiosarcoma Metastatic | Angiosarcoma of Skin

Japan
Sung Yong Oh
Merck KGaA, Darmstadt, Germany

Recruiting

Paclitaxel-Avelumab for Angiosarcoma (ASAP)

Angiosarcoma Metastatic

Korea, Republic of
Immune Oncology Research Institute

Recruiting

Cardiac Angiosarcoma International Registry (CAIR)

Cardiac Angiosarcoma

Armenia
Stella Pharma Corporation
Cancer Intelligence Care Systems, Inc.

Active, not recruiting

A Phase II Study by Using CICS-1 and SPM-011 Commissioned by CICS and STELLA PHARMA

Unresectable Angiosarcoma

Japan
National Taiwan University Hospital

Completed

Cytological Diagnosis of Hepatic Angiosarcoma and Its Histopathologic Correlation

Hepatic Angiosarcoma

Taiwan
Athenex, Inc.

Completed

A Study of Oraxol in Subjects With Cutaneous Angiosarcoma

Angiosarcoma of Skin

United States, United Kingdom, Taiwan, Hong Kong
Centre Oscar Lambret
Institut de Veille Sanitaire

Unknown

Identification, Molecular Epidemiology Angiosarcoma of the Liver France (ANGIHE)

Angiosarcoma

France
Sun Yat-sen University

Recruiting

Albumin-bound Paclitaxel Combined With Liposomal Doxorubicin in the Treatment of Advanced or Unresectable Angiosarcoma

Angiosarcoma Metastatic

China
Varun Monga, MBBS
Replimune, Inc.

Active, not recruiting

Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma

Angiosarcoma | Angiosarcoma, Adult

United States
Washington University School of Medicine

Active, not recruiting

Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma

Cutaneous Angiosarcoma

United States
Mayo Clinic

Terminated

Evaluating the Accuracy of Microvessel Ultrasound Imaging for Detecting Extent of Disease in Patients With Angiosarcoma of the Skin

Skin Angiosarcoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Study of T-VEC in Locally Advanced Cutaneous Angiosarcoma

Angiosarcoma of Skin

United States
University of California, Los Angeles
University of California, San Francisco; University of California, Irvine

Completed

UC Health Care Planning Study

Advanced Cancer | Advance Care Planning | Advance Directives

United States
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC; Amgen

Active, not recruiting

A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma

Sarcoma | Epithelioid Sarcoma | Cutaneous Angiosarcoma

United States
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

IBI363 Plus Bevacizumab With or Without Nab-Paclitaxel for Second-Line Treatment of Advanced Gastric Cancer

Advanced | Advan'ce'd

China
OHSU Knight Cancer Institute
Novartis Pharmaceuticals; Oregon Health and Science University

Completed

Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery

Stage III Soft Tissue Sarcoma AJCC v7 | Stage IV Soft Tissue Sarcoma AJCC v7 | Locally Advanced Leiomyosarcoma | Unresectable Leiomyosarcoma | Myxofibrosarcoma | Metastatic Malignant Peripheral Nerve Sheath Tumor | Metastatic Synovial Sarcoma | Metastatic Undifferentiated Pleomorphic Sarcoma | Unresectable... and other conditions

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma (DOSa)

Recurrent Osteosarcoma | Refractory Osteosarcoma | Metastatic Osteosarcoma | Metastatic Angiosarcoma | Recurrent Dedifferentiated Liposarcoma | Metastatic Dedifferentiated Liposarcoma | Recurrent Angiosarcoma | Refractory Dedifferentiated Liposarcoma

United States
Federation Francophone de Cancerologie Digestive
Société Nationale Française de Gastroentérologie

Recruiting

A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers (FFCD-2205)

Cholangiocarcinoma | Hepatoblastoma | Fibrolamellar Carcinoma | Hepatocholangiocarcinoma | Hepatic Epithelioid Hemangioendothelioma | Hepatic Neuroendocrine Carcinoma | Hepatic Carcinosarcomas | Hepatic Cystadenoma | Hepatic Leiomyosarcomas | Hepatic Angiosarcomas

France
ThalassaX Therapeutics United States Ltd

Not yet recruiting

A Study of CS231295 in Patients With Advanced Solid Tumors

Advanced Malignant Solid Tumors | Advance Solid Tumors

United States
Hospices Civils de Lyon
Centre François Baclesse, Centre de lutte contre le cancer (CLCC)

Completed

Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILE (PRIMHADRON)

Cancer | Chordoma | Sarcoma,Soft Tissue | Chondrosarcoma, Grade 3 | Osteosarcomas | Soft-tissue Sarcomas | Angiosarcomas | Cystic Carcinomas, Adenoid | Rhabdomyosarcoma Pleomorphic

France
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma

Recurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Adult Angiosarcoma

United States
Northwestern University
National Cancer Institute (NCI); Bayer

Completed

Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma

Recurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Adult Angiosarcoma

United States
National Cancer Institute (NCI)

Completed

Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery

Recurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Adult Angiosarcoma

United States
Centre Oscar Lambret
French Sarcoma Group; Study Group of Bone Tumors

Completed

Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced Angiosarcomas (ANGIO-TAX+)

Angiosarcoma

France
Italian Sarcoma Group

Recruiting

Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStars (ProStars)

Angiosarcoma

Italy
SingHealth Polyclinics

Completed

Increasing the Uptake of Advanced Directives in SingHealth Polyclinics

Advanced Medical Directive, a Legal Document Signed in Advance to State Healthcare Preferences

Singapore
M.D. Anderson Cancer Center
Cancer Cures 4 Kids

Withdrawn

Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma

Angiosarcoma

United States
The Netherlands Cancer Institute
Anticancer Fund, Belgium

Completed

Propranolol in Angiosarcoma

Angiosarcoma

Netherlands
Heidelberg University
Medical University of Graz; Medical University of Vienna; Hannover Medical School and other collaborators

Terminated

Evaluation of Votrient in Angiosarcoma (EVA)

Angiosarcoma

Germany, Austria
Assistance Publique Hopitaux De Marseille

Unknown

Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO) (PROPAN)

Angiosarcoma

France
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Recruiting

Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma

Cutaneous Sarcoma

United States
Sheffield Teaching Hospitals NHS Foundation Trust
Pfizer; Cancer Research UK; University of Birmingham

Completed

A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas (Axi-STS)

Soft Tissue Sarcoma

United Kingdom
Agenus Inc.

Withdrawn

AGEN2034 & AGEN1884 in Patients With Recurrent, Inoperable Angiosarcoma

Angiosarcoma
Northwestern University
Genentech, Inc.

Completed

Bevacizumab in Treating Patients With Angiosarcoma

Sarcoma

United States
UNICANCER

Completed

Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery

Sarcoma

France
Centre Oscar Lambret

Unknown

Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by Surgery

Sarcoma

France
Massachusetts General Hospital
Eisai Inc.

Active, not recruiting

Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)

Angiosarcoma | Epithelioid Hemangioendothelioma

United States
Memorial Sloan Kettering Cancer Center
Genentech, Inc.

Completed

Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes

Sarcoma | Leiomyosarcoma | Angiosarcoma | Histiocytoma | Malignant Fibrous

United States
Icahn School of Medicine at Mount Sinai
National Institute of Nursing Research (NINR)

Not yet recruiting

Tier Palliative Care For Patients With Advanced Heart Failure or Cancer (TIER-PC)

Advanced Heart Failure | Advanced Lung Cancer | Advanced Triple Negative Breast Cancer | Advanced Non-Colorectal Gastrointestinal Cancer

United States
UNICANCER

Recruiting

Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers (OASIS)

Advanced Breast Cancer | Advanced Gastric Cancer | Advanced Urothelial Cancer | Advanced Non Small Cell Lung Cancer (NSCLC)

France
Pfizer

Recruiting

An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers

Advanced Cancer | Advanced Malignancies

United States
Amsterdam UMC, location VUmc

Completed

Optimization of Systemic Treatment Strategies in Elderly Patients With Advanced Solid Malignancies (OptiMal)

Colorectum Advanced Malignancies | Breast Advanced Malignancies | Prostate Advanced Malignancies

Netherlands
Mayo Clinic

Recruiting

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Multiple Myeloma | Myelodysplastic Syndrome | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Advanced Pancreatic Carcinoma | Hematopoietic and Lymphoid System Neoplasm | Advanced Lung Carcinoma | Advanced Hepatocellular Carcinoma | Advanced Merkel Cell Carcinoma | Advanced Prostate Carcinoma | Advanced... and other conditions

United States
Shanghai Allink Biotherapeutics Co., Ltd.

Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors

Advanced Solid Tumors | Advanced Cancer

China, United States, Australia
Pfizer

Terminated

Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors

Advanced Solid Tumors | Advanced Cancer

United States

Clinical Trials on Advanced Angiosarcoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations